Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) traded at $39.78 at close of the session on Friday, May 30 and made a downward move of -5.33% on its previous day’s price.
Tonix Pharmaceuticals Holding Corp has a market cap of $291.38 million and is expected to release its quarterly earnings report in July.
Analysts tracking the company’s growth have also given it a consensus growth in revenue estimated at 2.55M, with a low of 2.5M and a high of 2.6M. The median projection represents growth squeezing down to 15.49% compared to sales growth for the corresponding quarter a year ago. According to analyst consensus estimates figures, the company’s yearly revenue forecast for current year is expected to hit 10.8M, or 6.99% up from figures reported last year.
On the other hand, looking at the outlook for the TNXP stock, short term indicators assign the stock an average of 100% Buy, while medium term indicators assign it an average of 100% Buy.
Based on estimates by 5 analysts, where scores have ranged from 1.00 for a strong buy to 5.00 for a strong sell, 1 have rated the Tonix Pharmaceuticals Holding Corp (TNXP) stock as a Hold, while 4 rate it as a Buy. 0 analyst(s) rate it as overweight while 0 of them rated it as underweight, whereas 0 suggest the stock as a Sell. The stock has an overall rating of Buy and investors could take advantage and scoop up stock of the company.
Looking further, we note the current price level is 51.67% off its SMA20 and 81.75% from its 50-day simple moving average. The RSI (14) is pointing at 74.56 while the volatility over the past week is 12.94% and jumps to 8.57% over the past one month. The beta value is 2.15, while the average true range (ATR) is currently pointing at 3.75.
